AKT1 and Huntington disease: Statistical analysis revealed significantly increased phosphorylation for all three molecules compared to an extended cohort of HD; however, basal phosphorylation of AKT and S6 was not significantly different compared to CVID patient-derived CD21pos and remarkably similar to CD21low B cells for most of the APDS patients (Figure 5B).